Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 20, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

26.0K

Lipid nanoparticles for gene delivery.

Yi Zhao1, Leaf Huang1

  • 1Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Advances in Genetics
|November 21, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting tumor-associated microbiome: A new aspect of modulating tumor microenvironment for cancer therapy.

Advanced drug delivery reviews·2025
Same author

Dynamic Covalent Hydrogel as a Single-Dose Vaccine Adjuvant for Sustained Antigen Release and Significantly Elevated Humoral Immunity.

Advanced healthcare materials·2024
Same author

Fusobacterium nucleatum carcinogenesis and drug delivery interventions.

Advanced drug delivery reviews·2024
Same author

Anti-stromal nanotherapeutics for hepatocellular carcinoma.

Journal of controlled release : official journal of the Controlled Release Society·2024
Same author

Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses.

Nature biotechnology·2023
Same author

The tumor therapeutic potential of long non-coding RNA delivery and targeting.

Acta pharmaceutica Sinica. B·2023
Same journal

Shaping mammalian genomes: The regulation and co-option of transposable elements in early development and gametogenesis.

Advances in genetics·2026
Same journal

Transposable elements in aging: From biomarkers to effectors.

Advances in genetics·2026
Same journal

Transposable elements in human cancer: Regulation, activation, and genomic consequences.

Advances in genetics·2026
Same journal

Retrotransposons as both "architects" and "saboteurs" in the nervous system.

Advances in genetics·2026
Same journal

Transposable element analysis in OMICS data.

Advances in genetics·2026
Same journal

The implication of lncRNAs in the regulation of inflammation.

Advances in genetics·2026
See all related articles

Lipid nanoparticles offer a safer, effective gene delivery alternative to viral vectors. These nonviral vectors show promise for treating tumors and other diseases, with ongoing clinical trials demonstrating their potential.

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Nanomedicine

Background:

  • Viral vectors present safety concerns in gene therapy.
  • Nonviral vectors offer a safer alternative but often have lower efficacy.
  • Lipid nanoparticles (LNPs) emerge as a promising platform balancing safety and efficacy.

Purpose of the Study:

  • To review current lipidic vectors for gene therapy applications.
  • To highlight LNP advancements in treating tumors and other diseases.
  • To present pharmacokinetic and toxicological data of successful lipid particles.

Main Methods:

  • Review of current literature on lipidic vectors.
  • Analysis of developed lipid nanoparticles for gene delivery.
  • Examination of pharmacokinetic and toxicological profiles.
Keywords:
Gene deliveryLipid nanoparticles

More Related Videos

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.8K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

15.3K

Related Experiment Videos

Last Updated: Apr 20, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

26.0K
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.8K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

15.3K
  • Summary of clinical trial data for successful lipid particles.

    • Main Results:

    • Lipid nanoparticles represent an ideal platform for safe and effective gene delivery.
    • Various lipidic vectors have been developed for therapeutic applications.
    • Successful lipid particles demonstrate favorable pharmacokinetic and toxicological profiles in clinical trials.

    Conclusions:

    • Lipid nanoparticles are a versatile and safe nonviral gene delivery system.
    • These vectors hold significant potential for treating various diseases, including cancer.
    • Further clinical evaluation of lipid nanoparticles is warranted.